成骨细胞来源的外泌体介导微小RNA-494影响骨质疏松症大鼠骨代谢与骨重建平衡

林维 李超艺 唐捷 张丕军

解剖学报 ›› 2024, Vol. 55 ›› Issue (3) : 302-310.

PDF(6301 KB)
欢迎访问《解剖学报》官方网站!今天是 English
PDF(6301 KB)
解剖学报 ›› 2024, Vol. 55 ›› Issue (3) : 302-310. DOI: 10.16098/j.issn.0529-1356.2024.03.007
细胞和分子生物学

成骨细胞来源的外泌体介导微小RNA-494影响骨质疏松症大鼠骨代谢与骨重建平衡

  •  林维   李超艺*    唐捷   张丕军
作者信息 +

Osteoblast-derived exosome mediating the effect of microRNA-494 on bone metabolism and bone remodeling balance in osteoporotic rats

  • LIN  Wei  LI Chao-yi*  TANG  Jie  ZHANG  Pi-jun#br#
Author information +
文章历史 +

摘要

目的 探讨成骨细胞来源的外泌体(Exo)中微小RNA(miR)-494对骨质疏松症(OP)大鼠骨代谢与骨重建平衡的影响及其机制。 方法 从MC3T3-E1成骨细胞系中分离鉴定Exo,并将miR-494电转至Exo,Real-time PCR测定miR-494表达水平。40只SD大鼠随机分为对照组、模型组、miR-494模拟剂(miR-494)组和miR-494抑制剂组,每组10只。除对照组外,其余3组大鼠切除卵巢构建OP模型。模型制作成功后,miR-494组与miR-494 抑制剂组分别接受含相应miRNA的Exo尾静脉注射,剂量为3×109个微粒。4周后,Micro-CT检测各组大鼠的骨参数,ELISA测定血清骨标志物,HE染色观察骨组织病理变化,抗酒石酸酸性磷酸酶(TRACP)染色检测破骨细胞数量,Western blotting测定骨重建相关蛋白及Toll样受体4(TLR4)相关通路蛋白表达水平。 结果 成功从MC3T3-E1细胞中分离得到典型杯状或圆形,直径约100 nm的Exo,其含有CD63、CD9、肿瘤易感性基因101(TSG101)、热休克蛋白70(HSP70)蛋白,且能被MC3T3-E1细胞摄取。经电转处理后,miR-494模拟剂和miR-494 抑制剂的Exo中miR-494的相对表达量明显升高和降低(P<0.05)。与模型组相比,miR-494组大鼠骨参数降低,血清骨标志物骨钙蛋白(BGP)、TRACP、Ⅰ型胶原C端肽(CTX-Ⅰ )升高,骨保护蛋白(OPG)、Ⅰ型前胶原N端肽( PⅠNP)降低,骨小梁结构紊乱,破骨细胞增加,骨组织内骨形态发生蛋白2(BMP-2)、Runt相关转录因子2(RUNX2)下调,核因子κB受体激活剂配体(RANKL)上调,TLR4、核因子κB (NF-κB) p65及髓样分化主要响应蛋白88(MyD88)上调(P<0.05)。而miR-494 抑制剂组情况则相反,骨参数和OPG、 PⅠNP 升高,BGP、TRACP、CTX-Ⅰ降低,骨结构恢复正常,破骨细胞减少,骨组织内BMP-2、RUNX2上调,RANKL下调,TLR4、NF-κB p65及MyD88下调(均P<0.05)。 结论 Exo传递miR-494可加重OP大鼠骨代谢异常,并抑制骨重建平衡,推测其作用机制可能与调控TLR4通路有关。

Abstract

Objective To investigate the effect of osteoblastderived exosome (Exo) mediating microRNA (miR)-494 on bone metabolism and bone remodeling balance in osteoporosis (OP) rats and its mechanism. Methods   Exosomes was isolated and identified from MC3T3-E1 osteoblast cell line and transferred to Exo by electrical transfer. Forty SD rats were randomly divided into control, model, miR-494 mimic (miR-494), and miR-494 inhibitor group, 10 rats in each group. The ovaries were removed to construct the OP model except the control group. After modeling, the miR-494 group and miR-494 inhibitor group received tail vein injections of exosomes containing the corresponding miRNA, at a dose of 3×109 particles. Four weeks later, bone parameters were detected in each group of rats by Micro-CT, serum bone markers were measured by ELISA, pathological changes in bone tissue were observed by HE staining, osteoclast numbers were detected by tartrate-resistant acid phosphatase (TRACP) staining, and the expression levels of bone remodeling-related proteins and toll-like receptor 4(TLR4) pathway-related proteins were determined by Western blotting. Results  Typical cup-shaped or round exosomes were successfully isolated with a diameter of about 100 nm from MC3T3-E1 cells, which contained CD63, CD9, tumor susceptibility gene 101(TSG101), heat shock protein 70(HSP70) proteins and can be taken up by MC3T3-E1 cells. Compared with the model group, the bone parameters of the rats in the miR-494 mimic group decreased, serum bone markers bone Gla protein (BGP), TRACP, C-terminal telopeptide of type Ⅰ collagen (CTX-Ⅰ) increased, osteoprotegerin (OPG), procollagen type Ⅰ N-terminal propeptide (PⅠNP) decreased, bone trabeculae structure was disordered, osteoclasts increased, bone morphogenetic protein 2(BMP-2), Runt related transcription factor 2(RUNX2) in bone tissue downregulated, receptor activator of nuclear factor kappa-B ligand (RANKL) upregulated, TLR4, nuclear factor kappa-B p65(NF-κB p65) and myeloid differentiation primary response 88(MyD88) upregulated (all P<0.05). In contrast, the situation of the miR-494 inhibitor group was opposite, bone parameters and OPG,  PⅠNP increased, BGP, TRACP, CTX-Ⅰ decreased, bone structure returned to normal, osteoclasts decreased, BMP-2, RUNX2 in bone tissue upregulated, RANKL downregulated, TLR4, NF-κB p65 and MyD88 downregulated (all P<0.05). Conclusion  The transfer of miRNA-494 by Exo aggravates abnormal bone metabolism in OP rats and inhibits bone remodeling balance, suggesting that the mechanism of action may be related to the regulation of TLR4 pathway.

关键词

骨质疏松症 / 微小RNA-494 / 外泌体 / 骨代谢 / 骨重建平衡 / 实时定量聚合酶链反应 / 免疫印迹法 / 大鼠

Key words

Osteoporosis / MicroRNA-494 / Exosome / Bone metabolism / Bone remodeling balance / Real-time PCR / Western blotting / Rat

引用本文

导出引用
林维 李超艺 唐捷 张丕军. 成骨细胞来源的外泌体介导微小RNA-494影响骨质疏松症大鼠骨代谢与骨重建平衡[J]. 解剖学报. 2024, 55(3): 302-310 https://doi.org/10.16098/j.issn.0529-1356.2024.03.007
LIN Wei LI Chao-yi TANG Jie ZHANG Pi-jun.
Osteoblast-derived exosome mediating the effect of microRNA-494 on bone metabolism and bone remodeling balance in osteoporotic rats
[J]. Acta Anatomica Sinica. 2024, 55(3): 302-310 https://doi.org/10.16098/j.issn.0529-1356.2024.03.007
中图分类号: R681   

参考文献

[1] Sabri SA, Chavarria JC, Ackert-Bicknell C, et al. Osteoporosis: an update on screening, diagnosis, evaluation, and treatment[J]. Orthopedics, 2023, 46(1):e20-e26.
[2] Loundagin LL, Cooper DML. Towards novel measurements of remodeling activity in cortical bone: implications for osteoporosis and related pharmaceutical treatments[J]. Eur Cell Mater, 2022, 43(1):202-227.
[3] Zhang TJ, Zhang W, Bian LG, et al. Protective effect of resveratrol on osteoporosis in ovariectomized rats [J]. Acta Anatomica Sinica, 2012,43(5):679-684. (in Chinese)
张铁军,张伟,边立功,等.白藜芦醇对去卵巢大鼠骨质疏松症的保护作用[J].解剖学报,2012,43(5):679-684.
[4] Waqas MY, Javid MA, Nazir MM, et al. Extracellular vesicles and exosome: insight from physiological regulatory perspectives[J]. J Physiol Biochem, 2022, 78(3):573-580.
[5] Qin W, Liu L, Wang Y, et al. miR-494 inhibits osteoblast differentiation by regulating BMP signaling in simulated microgravity[J]. Endocrine, 2019, 65(2):426-439.
[6] Zhou HQ, Wu DD, Yang K, et al. Exosomes that transmit specific miRNAs can regulate osteogenesis and promote angiogenesis [J]. Chinese Tissue Engineering Research, 2022,26 (7): 1107-1112. (in Chinese)
周洪琴,吴丹丹,杨琨,等.传递特定miRNA的外泌体可调控成骨并促进成血管[J].中国组织工程研究,2022,26(7):1107-1112.
[7] Wang L, You X, Zhang L, et al. Mechanical regulation of bone remodeling[J]. Bone Res, 2022, 10(1):16.
[8] Oton-Gonzalez L, Mazziotta C, Iaquinta MR, et al. Genetics and epigenetics of bone remodeling and metabolic bone diseases[J]. Int J Mol Sci, 2022, 23(3):1500.
[9] Wang YH, Liu H, Li Y, et al. Meta analysis of risk factors for primary osteoporosis in China [J]. Chinese Journal of Osteoporosis, 2021,27 (12): 1730-1738. (in Chinese)
王雨荷,刘红,李艳,等.中国原发性骨质疏松症危险因素的Meta分析[J].中国骨质疏松杂志,2021,27(12):1730-1738.
[10] Lu GD, Cheng P, Liu T, et al. BMSC-derived exosomal miR-29a promotes angiogenesis and osteogenesis[J]. Front Cell Dev Biol, 2020, 8(1):608521.
[11] Zhang Y, Cao X, Li P, et al. microRNA-935-modified bone marrow mesenchymal stem cells-derived exosomes enhance osteoblast proliferation and differentiation in osteoporotic rats[J]. Life Sci, 2021, 272(2):119204.
[12] Zhang XY, Xu LQ, Zhang LJ, et al. Study on the inhibition of osteoblast differentiation by microvascular endothelial cells transporting miR-223-3p through extracellular vesicles under simulated weightlessness [J]. Journal of Air Force Military Medical University, 2023,44 (1): 23-29. (in Chinese)
张晓雁,徐丽群,张丽君,等.模拟失重下微血管内皮细胞通过外泌体转运miR-223-3p抑制成骨细胞分化的研究[J].空军军医大学学报,2023,44(1):23-29.
[13] Min SK, Kim M, Park JB. Bone morphogenetic protein 2-enhanced osteogenic differentiation of stem cell spheres by regulation of Runx2 expression[J]. Exp Ther Med, 2020, 20(5):79.
[14] Honma M, Ikebuchi Y, Suzuki H. Mechanisms of RANKL delivery to the osteoclast precursor cell surface[J]. J Bone Miner Metab, 2021, 39(1):27-33.
[15] Mei PJ, Jiang ZhQ, Gong HS, et al. Study on the effects of self-made traditional Chinese medicine decoction on bone metabolism biochemical indicators and blood osteocalcin in patients with osteoporosis [J]. Northern Pharmacology, 2022,19 (5): 152-154. (in Chinese)
梅平均,姜志强,龚辉松,等.自拟中药汤剂对骨质疏松患者骨代谢生化指标和血中骨钙素的影响研究[J].北方药学,2022,19(5):152-154.
[16] Vasikaran SD, Miura M, Pikner R, et al. Practical considerations for the clinical application of bone turnover markers in osteoporosis[J]. Calcif Tissue Int, 2023, 112(2):148-157.

[17] Cheng M, Xiang T, Wu YL, et al. Effects of bone marrow mesenchymal stem cells on mechanical dynamics and BALP/CTX-1 expression in rats with osteoporotic vertebral fracture [J]. Journal of Sichuan University (Medical Edition), 2022,53 (5): 815-820. (in Chinese)

程明,向桃,吴杨玲,等.骨髓间充质干细胞对骨质疏松性椎体骨折大鼠力学动态及BALP/CTX-1表达的影响[J].四川大学学报(医学版),2022,53(5):815-820.

[18] Li X, Cheng J, Dong B, et al. Common variants of the OPG gene are associated with osteoporosis risk: a meta-analysis[J]. Genet Test Mol Biomarkers, 2021, 25(9):600-610.
[19] Gillett MJ, Vasikaran SD, Inderjeeth CA. The role of PINP in diagnosis and management of metabolic bone disease[J]. Clin Biochem Rev, 2021, 42(1):3-10.
[20] Cao Y, Han X, Wang Z, et al. TLR4 knockout ameliorates streptozotocin-induced osteoporosis in a mouse model of diabetes[J]. Biochem Biophys Res Commun, 2021, 546: (2)185-191.
[21] Shen XM, Li CC, Lan C, et al. TLR4 inhibition ameliorated glucolipotoxicity-induced differentiation suppression in osteoblasts via RIAM regulation of NF-κB nuclear translocation[J]. Mol Cell Endocrinol, 2022, 543(1):111539.
[22] Xie H, Cao L, Ye L, et al. The miR-1906 mimic attenuates bone loss in osteoporosis by down-regulating the TLR4/MyD88/NF-κB pathway[J]. Physiol Int, 2021, 107(4):469-478.

基金

海南省卫生健康行业科研项目

PDF(6301 KB)

Accesses

Citation

Detail

段落导航
相关文章

/